|
Market Cap (2-Jul) $356,619,552 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 18 March 2021, 10:59. The announcement is not marked as price sensitive, and is 16 page(s) in length and 235.94kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 0.024% short sold according to ASIC data. It was ranked the 528th most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Appendix 2A | 18 March 2021, 10:59 |
| Immutep collaborates with MSD for phase 2b head & neck trial | 16 March 2021, 8:17 |
| S&P DJI Announces March 2021 Quarterly Rebalance | 12 March 2021, 17:02 |
| Immutep secures second US patent grant for eftilagimod alpha | 9 March 2021, 16:14 |
You must be logged in to post a reply.
